Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in the following upcoming investor conferences: 25th ...
Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki ...
NEW YORK and SALT LAKE CITY - Citeline announced an expanded partnership with Recursion (NASDAQ:RXRX) on Tuesday to integrate real-world data capabilities into the biotech company’s drug development ...
NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with ...
An update from Recursion Pharmaceuticals ( (RXRX)) is now available. On March 25, 2026, Recursion Pharmaceuticals announced that seasoned oncology drug developer Vicki Goodman, M.D., will become Chief ...
From evolving scam psychology to emerging AI privacy risks, here's what's on our radar ahead of this year's RSAC Conference in San Francisco.
The best systems programming books focus on both theory and hands-on practice, making tough topics easier to grasp. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results